The Competition Tribunal has approved with conditions the acquisition of Mediclinic by a consortium comprising its shareholder Remgro and Switzerland’s Mediterranean Shipping Company (MSC).

Remgro, an investment holding company chaired by Johann Rupert that owns 44.56% of Mediclinic, is entering into a 50:50 partnership with MSC to acquire the rest of Mediclinic...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.